Correction to: Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study - Summary - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Correction to: Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study

  • September 15, 2025

Share

Objective:

To correct the name of a co-author in the previously published manuscript.

Key Findings:
  • Correction made to the author list of the original study.
Interpretation:

The correction ensures accurate attribution of authorship in the published research.

Limitations:
Conclusion:

Accurate authorship is crucial for academic integrity and proper citation.

Original Source(s)

Correction to: Fidaxomicin for Clostridioides difficile infection in patients with inflammatory bowel disease: a multicenter retrospective cohort study

  • September 15, 2025

Related Content

Reply to Olle et al.

Short Antibiotics Match Outcomes in Pneumonia

Only about one in ten hospitalized patients qualified for shorter therapy in a large US analysis

Effectiveness of Ampicillin-Sulbactam Versus Ceftriaxone for the Initial Treatment of Community-Acquired Pneumonia in Older Adults: A Target Trial Emulation Study